Who makes Microtracer [14C]ACP-196?

Microtracer [14C]ACP-196 is developed by Acerta Pharma BV.

What development phase is Microtracer [14C]ACP-196 in?

Microtracer [14C]ACP-196 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Microtracer [14C]ACP-196

Acerta Pharma BV · Phase 1 active Small molecule

At a glance

Generic name	Microtracer [14C]ACP-196
Sponsor	Acerta Pharma BV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Microtracer [14C]ACP-196 CI brief — competitive landscape report
Microtracer [14C]ACP-196 updates RSS · CI watch RSS
Acerta Pharma BV portfolio CI